FDA recall, , Moderate risk
ImpactLife Red Blood Cells, Leukocytes Reduced
Red Blood Cells, Leukocytes Reduced were distributed after testing non-reactive for anti-HCV but from a donor who previously tested repeatedly reactive.
Recall ended Jun 22, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
ImpactLife distributed Red Blood Cells, Leukocytes Reduced that tested non-reactive for anti-HCV, but were collected from a donor who previously tested repeatedly reactive for anti-HCV. The distribution occurred in Illinois and Missouri. ImpactLife began the recall on May 2, 2025.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Company
- ImpactLife
- Hazard
- Blood donor screening
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99004
- Recall number
- B-0078-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
Archived
